Nussbaumer B, Morgan LC, Reichenpfader U, Greenblatt A, Hansen RA, Van Noord M, Lux L, Gaynes BN, Gartlehner G. Efficacy and risk of harms of immediate-versus extended-release second-generation antidepressants: a systematic review with network meta-analysis. CNS Drugs. 2014 Aug;28(8):699-712. doi: 10.1007/s40263-014-0169-z
Garbutt JC, Greenblatt AM, West SL, Morgan LC, Kampov-Polevoy A, Jordan HS, Bobashev GV. Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence. Addiction. 2014 Aug;109(8):1274-84. doi: 10.1111/add.12557
Nussbaumer B, Morgan LC, Reichenpfader U, Greenblatt A, Hanson RA, Van Noord MG, Lux L, Gaynes BN, Gartlehner G. Immediate vs. extended release second-generation antidepressants in the treatment of major depressive disorder: a systematic review. Poster presented at the 22nd European Congress of Psychiatry; March 3, 2014. Munich, Germany.
Pinto M, Greenblatt AM, Thomas T, Clochesy J. Evaluating the critical intervention parameters of eSMART-MH from the young adult's perspective: initial findings of a behavioral health avatar-based intervention for depressive symptoms. Poster presented at the 27th Annual Children's Mental Health Research & Policy Conference; March 2, 2014. Tampa, FL.
Reichenpfader U, Gartlehner G, Morgan LC, Greenblatt A, Nussbaumer B, Hansen RA, Van Noord M, Lux L, Gaynes BN. Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis. Drug Saf. 2014 Jan;37(1):19-31. doi: 10.1007/s40264-013-0129-4